Strategizing the Treatment Approach to Acute Myeloid Leukemia

Strategizing the Treatment Approach to Acute Myeloid Leukemia

Review Data

Q: Is the topic relevant to the journal area of interest? Is it contemporary and interesting for

researchers?

A: Excellent

 

Abstract & Keywords

Q: Are all required components included in the abstract? Are the keywords appropriately chosen?

A: Very good

 

Goal

Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?

A: Very good

 

Structure

Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?

A: Very good

 

Tools and Methods

Q: Are methods the author uses adequate and well used?

A: Good

 

Discussion & Conclusion

Q: Is it related to the results presented before? Do you consider them as coherent?

A: Very good

 

Comments:

The article is a timely and adequately detailed and thorough discussion of the ongoing developments in treatment strategies for acute myeloid leukemia (AML), especially in terms of the mechanisms of cell signaling and biology of cytogenetic and molecular markers that drive AML and promote leukemogenesis. The authors conclude that targeted treatment now changes prognostic models as mutations of poor prognosis can be subdued with therapy, and the outcomes of ongoing clinical trials are intriguing for the potential to achieve durable remission in AML without the use of intense chemotherapy and preserving patient functional status and quality of life.

 

Literature

Q: Does the author utilize relevant literature?

A: Very good

 

Author's knowledge

Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?

A: Very good

 

Length

Q: Is the length of the paper adequate to the significance of the topic? Do you suggest shortening the paper without losing its value?

A: Good

 

Figures & Tables

Q: Does the author use them suitably? Are legend and notations clear?

A: Not applicable.

 

Writing style

Q: Is it clear and understandable?

A: Very good

Comments: A few minor issues were noted:

·       ozogamicin” and “trials” are misspelled.

·       In the 7th sentence of the last paragraph of Maintenance Therapy, “impact” must be removed.

·       Articles (a, an, or the), commas, and hyphens were missing in some places.

 

Further comments on the paper

Comments: This review highlights the discovery of treatment strategies to improve patient outcomes and ongoing research in acute myeloid leukemia (AML). It discusses the timing of first therapy, non-intense treatment regimens achieving remission, and new targets for directed therapy; key clinical trials are referenced, which expand the discussion of newly approved agents for AML. This is significant as treatment discovery provides therapeutic opportunity to older patients and populations previously excluded from intense induction chemotherapy.

 

Q: Would you recommend this manuscript for further publication?

A: Yes - Suitable to be published

If you have any questions and clarifications you can write to the journal.

Thanks,
Science Repository Team

 
 

Author Info

Corresponding Author
Laura Finn
Division of Hematology and Bone Marrow Transplant, Department of Internal Medicine, Ochsner Health, New Orleans, Louisiana, USA

Article Info

Article Type
Review Article
Publication history
Received: Wed 23, Dec 2020
Accepted: Tue 12, Jan 2021
Published: Thu 28, Jan 2021
Copyright
© 2023 Laura Finn. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2021.01.08